Coban Harun, Barutcu Atas Dilek, Tugcu Murat, Kursun Meltem, Cimsit Canan, Asicioglu Ebru, Arikan Hakki, Tuglular Serhan, Velioglu Arzu
From the Department of Internal Medicine, Division of Nephrology, Marmara University School of Medicine, Istanbul, Turkey.
Exp Clin Transplant. 2024 Mar;22(3):214-222. doi: 10.6002/ect.2023.0050.
Sarcopenia is common in chronic kidney disease and associated with increased mortality. We investigated the prevalence of sarcopenia, defined as low muscle mass by the psoas muscle index, in endstage renal disease patients on waiting lists for kidney transplant and determined its association with prognostic nutritional index, C-reactive protein-toalbumin ratio, cardiovascular events, and mortality.
Our study included 162 patients with end-stage renal disease and 87 agematched healthy controls. We calculated nutritional status as follows: prognostic nutritional index = (10 × albumin [g/dL]) + (0.005 × total lymphocyte count (×103/μL]) and C-reactive protein-to-albumin ratio. We gathered demographic and laboratory data from medical records.
Patients with end-stage renal disease had a mean age of 44.7 ± 14.2 years; follow-up time was 3.37 years (range, 0.35-9.60 y). Although patients with endstage renal disease versus controls had higher prevalence of sarcopenia (16.7% vs 3.4%; P = .002) and C-reactive protein-to-albumin ratio (1.47 [range, 0.12-37.10] vs 0.74 [range, 0.21-10.20]; P < .001), prognostic nutritional index was lower (40 [range, 20.4-52.2] vs 44 [range, 36.1-53.0]; P < .001). In patients with end-stage renal disease with and without sarcopenia, prognostic nutritional index (P = .005) was lower and C-reactive protein-to-albumin ratio (P = .041) was higher in those with versus those without sarcopenia. Among 67 patients on waiting lists who received kidney transplants, those without sarcopenia had better 5-year patient survival posttransplant than those with sarcopenia (P = .001). Multivariate regression analysis showed sarcopenia and low prognostic nutritional index were independentrisk factors for mortality among patients with end-stage renal disease.
Sarcopenia was ~5 times more frequent in patients with end-stage renal disease than in healthy controls and was positively correlated with the prognostic nutritional index. Sarcopenia was an independent risk factor for mortality in patients on transplant waiting lists.
肌肉减少症在慢性肾脏病中很常见,且与死亡率增加相关。我们调查了等待肾移植的终末期肾病患者中肌肉减少症的患病率(通过腰大肌指数定义为低肌肉量),并确定了其与预后营养指数、C反应蛋白与白蛋白比值、心血管事件和死亡率的关联。
我们的研究纳入了162例终末期肾病患者和87例年龄匹配的健康对照。我们按如下方式计算营养状况:预后营养指数 =(10×白蛋白[克/分升])+(0.005×总淋巴细胞计数[×10³/微升])以及C反应蛋白与白蛋白比值。我们从病历中收集人口统计学和实验室数据。
终末期肾病患者的平均年龄为44.7±14.2岁;随访时间为3.37年(范围0.35 - 9.60年)。尽管与对照组相比,终末期肾病患者肌肉减少症的患病率更高(16.7%对3.4%;P = 0.002)且C反应蛋白与白蛋白比值更高(1.47[范围0.12 - 37.10]对0.74[范围0.21 - 10.20];P < 0.001),但预后营养指数更低(40[范围20.4 - 52.2]对44[范围36.1 - 53.0];P < 0.001)。在有和没有肌肉减少症的终末期肾病患者中,有肌肉减少症的患者预后营养指数更低(P = 0.005)且C反应蛋白与白蛋白比值更高(P = 0.041)。在67例等待肾移植的患者中,没有肌肉减少症的患者移植后5年的患者生存率优于有肌肉减少症的患者(P = 0.001)。多因素回归分析显示,肌肉减少症和低预后营养指数是终末期肾病患者死亡的独立危险因素。
终末期肾病患者中肌肉减少症的发生率比健康对照高约5倍,且与预后营养指数呈正相关。肌肉减少症是移植等待名单上患者死亡的独立危险因素。